| |
| |
|
| Insider
Information: |
Burrell Terry-Ann |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
138,951 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,556,081 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,951 |
|
|
| Total
Value |
$2,556,081 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beam Therapeutics Inc. |
BEAM |
|
2024-04-26 |
82,637 |
2020-09-18 |
0 |
Premium* |
|
|
Recursion Pharmaceuticals, Inc. |
RXRX |
Director |
2024-04-01 |
56,314 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2020-09-18 |
4 |
OE |
$13.68 |
$99,987 |
D/D |
7,309 |
7,309 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2021-01-04 |
4 |
AS |
$78.05 |
$2,044,485 |
D/D |
(25,000) |
7,309 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2021-01-04 |
4 |
OE |
$13.68 |
$342,000 |
D/D |
25,000 |
32,309 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
24,809 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2021-06-28 |
4 |
AS |
$103.86 |
$4,846,016 |
D/D |
(45,000) |
24,809 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2021-06-28 |
4 |
OE |
$13.68 |
$615,600 |
D/D |
45,000 |
69,809 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
40,065 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CFO |
• – – |
2022-03-31 |
4 |
S |
$59.11 |
$105,630 |
D/D |
(1,787) |
38,278 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-18 |
4 |
AS |
$45.14 |
$2,130,382 |
D/D |
(47,195) |
31,277 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-18 |
4 |
OE |
$13.68 |
$545,640 |
D/D |
39,886 |
78,472 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-23 |
4 |
AS |
$45.02 |
$244,290 |
D/D |
(5,426) |
31,277 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-23 |
4 |
OE |
$13.68 |
$74,228 |
D/D |
5,426 |
36,703 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-24 |
4 |
AS |
$45.01 |
$666,657 |
D/D |
(14,810) |
31,277 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-24 |
4 |
OE |
$13.68 |
$202,601 |
D/D |
14,810 |
46,087 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-26 |
4 |
AS |
$45.16 |
$49,763 |
D/D |
(1,102) |
31,277 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-26 |
4 |
OE |
$13.68 |
$15,075 |
D/D |
1,102 |
32,379 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-27 |
4 |
AS |
$45.08 |
$1,629,747 |
D/D |
(36,152) |
31,277 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-01-27 |
4 |
OE |
$13.68 |
$494,559 |
D/D |
36,152 |
67,429 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-04-03 |
4 |
AS |
$30.31 |
$74,381 |
D/D |
(2,454) |
49,303 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2023-04-04 |
4 |
AS |
$29.09 |
$63,598 |
D/D |
(2,186) |
47,117 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
75,583 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2024-04-01 |
4 |
AS |
$32.12 |
$174,926 |
D/D |
(5,446) |
70,137 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Chief Financial Officer |
• – – |
2024-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
82,637 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
120,311 |
|
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
126,561 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
